---
title: "Why Britain's FTSE giants find it so hard to crack America: Hamish McRae"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295316231.md"
description: "From Tesco's Fresh & Easy adventure, to HSBC and M&S's ambitions and giant mergers, making it big in the US is not easy, hence market disdain for AstraZeneca's idea."
datetime: "2026-08-09T06:40:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295316231.md)
  - [en](https://longbridge.com/en/news/295316231.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295316231.md)
generator: "portal-rs"
---

# Why Britain's FTSE giants find it so hard to crack America: Hamish McRae

From Tesco's Fresh & Easy adventure, to HSBC and M&S's ambitions and giant mergers, making it big in the US is not easy, hence market disdain for AstraZeneca's idea.

### Related Stocks

- [HSBC.US](https://longbridge.com/en/quote/HSBC.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [HSBH.US](https://longbridge.com/en/quote/HSBH.US.md)
- [00005.HK](https://longbridge.com/en/quote/00005.HK.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [TSCO.UK](https://longbridge.com/en/quote/TSCO.UK.md)
- [MKS.UK](https://longbridge.com/en/quote/MKS.UK.md)
- [HSBA.UK](https://longbridge.com/en/quote/HSBA.UK.md)
- [TSCDY.US](https://longbridge.com/en/quote/TSCDY.US.md)
- [DTIW.SG](https://longbridge.com/en/quote/DTIW.SG.md)

## Related News & Research

- [AstraZeneca Reports Positive Results Of SANOVO Phase III Trial In China](https://longbridge.com/en/news/297606938.md)
- [Key facts: LSE:AZN Zegfrovy buy; SANOVO PFS; Wan Ling Martello named](https://longbridge.com/en/news/297611733.md)
- [REG - AstraZeneca PLC - AstraZeneca completes agreement for Zegfrovy](https://longbridge.com/en/news/297603898.md)
- [AstraZeneca Shares Dual Oncology Clinical and Regulatory Victories](https://longbridge.com/en/news/297649754.md)
- [HSBC buys 36 Fnac Darty shares at EUR 34.6 during takeover period, filing shows](https://longbridge.com/en/news/297198605.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**